Ibogaine for addiction treatment

In 1962, a prominent scientist by the name of Howard Lotsof and his six friends decided to ingest ibogaine powder. The reason why? They were struggling mightily with heroin addiction and were on their last legs. The result – five of the six immediately quit heroin. 

Far from a robust longitudinal study, the results fascinated many. Fast-forward to the present and we know ibogaine has the potential to ameliorate a host of maladies. We’re treated to a comprehensive summary of the future of ibogaine in  “Ibogaine Use in Addiction Treatment: An Overview.” The global drug addiction treatment market is expected to reach a staggering $37.7 billion by 2027. It is hard to find anyone who does not know someone struggling with an addiction. It is for this reason that ibogaine is now on the radar of leading life-science firms.

Read full article here: https://investingnews.com/ibogaine-for-addiction-treatment/

What if everyone took psychedelics

Psychedelics have a long history in popular culture. Typically viewed as counter-culture, primarily due to their Schedule-1 classification in the US and a Class-A classification in the UK, psychedelics are not entirely legal as any savvy reader could tell you. With that said, we have certainly witnessed waves of psychedelic renaissances over the years. Yet, it would appear that the last 5 years have been different. 

As Ed Prideaux details in “The worldview-changing drugs poised to go mainstream,” the difference we’re experiencing today is the psychiatric acceptance of psychedelics like ibogaine to treat a range of conditions: childhood autism, depression, criminal recidivism, schizophrenia, and alcoholism. A mind-boggling 6,000 studies covering 40,000 plus patients have been completed and the data could not be clearer.

Read full article here: https://www.bbc.com/future/article/20210906-what-if-everyone-took-psychedelics